Journal article
Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading
Cancer immunology research, Vol.8(1), pp.7-18
01/2020
DOI: 10.1158/2326-6066.CIR-19-0251
PMCID: PMC6946848
PMID: 31719059
Abstract
Loss of target antigens in tumor cells has become one of the major hurdles limiting the efficacy of adoptive cell therapy (ACT)-based immunotherapies. The optimal approach to overcome this challenge includes broadening the immune response from the initially targeted tumor-associated antigen (TAA) to other TAAs expressed in the tumor. To induce a more broadly targeted antitumor response, we utilized our previously developed Re-energized ACT (ReACT), which capitalizes on the synergistic effect of pathogen-based immunotherapy and ACT. In this study, we showed that ReACT induced a sufficient endogenous CD8
T-cell response beyond the initial target to prevent the outgrowth of antigen loss variants in a B16-F10 melanoma model. Sequentially, selective depletion experiments revealed that Batf3-driven cDC1s were essential for the activation of endogenous tumor-specific CD8
T cells. In ReACT-treated mice that eradicated tumors, we observed that endogenous CD8
T cells differentiated into memory cells and facilitated the rejection of local and distal tumor rechallenge. By targeting one TAA with ReACT, we provided broader TAA coverage to counter antigen escape and generate a durable memory response against local relapse and metastasis.
.
Details
- Title: Subtitle
- Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading
- Creators
- Gang Xin - Versiti Blood Center of WisconsinAchia Khatun - Versiti Blood Center of WisconsinPaytsar Topchyan - Medical College of WisconsinRyan Zander - Versiti Blood Center of WisconsinPeter J Volberding - Medical College of WisconsinYao Chen - Versiti Blood Center of WisconsinJian Shen - Versiti Blood Center of WisconsinChunmei Fu - Roswell Park Cancer InstituteAimin Jiang - Roswell Park Cancer InstituteWilliam A See - Medical College of WisconsinWeiguo Cui - Versiti Blood Center of Wisconsin
- Resource Type
- Journal article
- Publication Details
- Cancer immunology research, Vol.8(1), pp.7-18
- DOI
- 10.1158/2326-6066.CIR-19-0251
- PMID
- 31719059
- PMCID
- PMC6946848
- ISSN
- 2326-6066
- eISSN
- 2326-6074
- Grant note
- R01 CA198105 / NCI NIH HHS R01 AI125741 / NIAID NIH HHS T32 GM080202 / NIGMS NIH HHS
- Language
- English
- Date published
- 01/2020
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9984297319902771
Metrics
10 Record Views